EQUATE- octocrylene, homosalate, octisalate, avobenzone cream

Equate by

Drug Labeling and Warnings

Equate by is a Otc medication manufactured, distributed, or labeled by WALMART INC, Apollo Health and Beauty Care. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredients

Avobenzone 3%

Homosalate 5%

Octisalate 5%

Octocrylene 7%

Purpose

Sunscreen

Uses

• Helps prevent sunburn
• If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.

Warnings

For External use only.

Do not use

• On damaged or broken skin.

When using this product

• Keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if

• rash occurs.

Keep out of reach of children

• If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• Apply generously and evenly 15 minutes before sun exposure.
• reapply at least every 2 hours.
• use a water resistant sunscreen if swimming or sweating.

Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Sopectrum SPF value of 15 or higher and other sun protection measures including:

• Limit time in the sun, especially from 10 am-2 pm.
• Wear long sleeved shirts, pants, hats and sunglasses.
• Children under 6 months of age: Ask a doctor.

Inactive Ingredients

Water (Aqua), Glycerin, Butyloctyl Salicylate, Dimethicone, Isopropyl Isostearate, Propanediol, Cetyl Alcohol, Octyldodecanol, Phenoxyethanol, Bahenyl Alcohol, PEG-100 Stearate, Cetearyl Alcohol, Cetearyl Glucoside, Ammonium Acryloyldimethyltaurate/Beheneth-25 Methacrylate Crosspolymer, Fragrance (Parfum), Retinyl Palmitate, Ethylhexylglycerin, Tocopherol, Tetrasodium Glutamate Diacetate, Polyacrylamide, Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate, Citric Acid, C13-14 Isoparaffin, Laureth-7, Hydrolyzed Soy Protein, Panthenol, Centella Asiatica Extract.

Questions/comments?

1-888-287-1915

PDP

PDP-1

INGREDIENTS AND APPEARANCE

EQUATE 
octocrylene, homosalate, octisalate, avobenzone cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 79903-316
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM)	OCTOCRYLENE	70 mg  in 1 g
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S)	HOMOSALATE	50 mg  in 1 g
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX)	AVOBENZONE	30 mg  in 1 g
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W)	OCTISALATE	50 mg  in 1 g

Inactive Ingredients
Ingredient Name	Strength
OCTYLDODECANOL (UNII: 461N1O614Y)
AMMONIUM ACRYLOYLDIMETHYLTAURATE/BEHENETH-25 METHACRYLATE CROSSPOLYMER (52000 MPA.S) (UNII: LZ291VH90H)
ISOPROPYL ISOSTEARATE (UNII: C67IXB9Y7T)
DIMETHICONE (UNII: 92RU3N3Y1O)
TETRASODIUM GLUTAMATE DIACETATE (UNII: 5EHL50I4MY)
PROPANEDIOL (UNII: 5965N8W85T)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
GLYCERIN (UNII: PDC6A3C0OX)
FRAGRANCE CLEAN ORC0600327 (UNII: 329LCV5BTF)
CITRIC ACID (UNII: 2968PHW8QP)
HYDROLYZED SOY PROTEIN (ENZYMATIC; 2000 MW) (UNII: 1394NXB9L6)
BUTYLOCTYL SALICYLATE (UNII: 2EH13UN8D3)
CETYL ALCOHOL (UNII: 936JST6JCN)
PEG-100 STEARATE (UNII: YD01N1999R)
POLYACRYLAMIDE (10000 MW) (UNII: E2KR9C9V2I)
WATER (UNII: 059QF0KO0R)
BEHENYL ALCOHOL (UNII: 9G1OE216XY)
CETEARYL GLUCOSIDE (UNII: 09FUA47KNA)
CETEARYL ALCOHOL (UNII: 2DMT128M1S)
RETINYL PALMITATE (UNII: 1D1K0N0VVC)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
TOCOPHEROL (UNII: R0ZB2556P8)
PANTHENOL (UNII: WV9CM0O67Z)
PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE (UNII: 255PIF62MS)
C13-14 ISOPARAFFIN (UNII: E4F12ROE70)
LAURETH-7 (UNII: Z95S6G8201)
CENTELLA ASIATICA TRITERPENOIDS (UNII: 4YS74Q4G4J)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 79903-316-17	48 g in 1 JAR; Type 0: Not a Combination Product	04/01/2025

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	04/01/2025

Labeler - WALMART INC (051957769)

Registrant - Apollo Health and Beauty Care (201901209)

Establishment
Name	Address	ID/FEI	Business Operations
Apollo Health and Beauty Care		201901209	manufacture(79903-316)